Astana Biomed Group, an authorized Abcam distributor in Central Asia

Cancer

MI-2 (ab254237)

Description:
Menin-MLL interaction inhibitor that blocks cell proliferation and induces apoptosis.
Application:
Reactivity:
Conjugate:

MMPSI, Caspase-3/7 Inhibitor I, caspase 3 and 7 inhibitor (ab145046)

Description:
Selective caspase 3 and 7 inhibitor
Application:
Reactivity:
Conjugate:

Momelotinib (CYT387), ATP-competitve JAK 1/2 selective inhibitor (ab141372)

Description:
Potent ATP-competitve JAK 1/2 selective inhibitor
Application:
Reactivity:
Conjugate:

Native Adenovirus type 40 protein (ab123997)

Description:
Application:
Reactivity:
Conjugate:

NSC 663284 (DA3003-1), Cdc25 inhibitor (ab144408)

Description:
Potent, cell-permeable, irreversible non-selective Cdc25 inhibitor
Application:
Reactivity:
Conjugate:

NU6102, CDK1/cyclin B and CDK2/cyclin A3 inhibitor (ab144317)

Description:
Potent CDK1/cyclin B and CDK2/cyclin A3 inhibitor. Antiproliferative agent.
Application:
Reactivity:
Conjugate:

Oleanolic acid, Natural triterpenoid (ab141066)

Description:
Natural triterpenoid
Application:
Reactivity:
Conjugate:

Olomoucine II, CDK/cyclin inhibitor (ab141238)

Description:
CDK/cyclin inhibitor
Application:
Reactivity:
Conjugate:

Olomoucine, ATP-competitive CDK inhibitor (ab120938)

Description:
ATP-competitive CDK inhibitor
Application:
Reactivity:
Conjugate:

P19 nuclear extract lysate (ab14880)

Description:
P19 nuclear extract lysate
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.